Cargando…

Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era

Hereditary tyrosinemia type 1 (HT-1) is a metabolic disorder caused by a defect in tyrosine degradation. Without treatment, symptoms of hepatomegaly, renal tubular dysfunction, growth failure, neurologic crises resembling porphyrias, rickets and possible hepatocellular carcinoma can develop. The use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imseis, Essam M, Bynon, John S, Thornhill, Chad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368626/ https://www.ncbi.nlm.nih.gov/pubmed/28396719 http://dx.doi.org/10.4254/wjh.v9.i9.487

Ejemplares similares

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Revisiting hereditary tyrosinemia Type 1—spectrum of radiological findings
por: Shaikh, Sana, et al.
Publicado: (2018)

Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
por: Hajji, Hela, et al.
Publicado: (2022)

Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts
Publicado: (1985)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
por: Sarodaya, Neha, et al.
Publicado: (2020)

The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening
por: Priestley, Jessica R. C., et al.
Publicado: (2020)

Rare Case of Pediatric Post-transplant Lymphoproliferative Disorder Presenting With Pleural Masses Complicated by Pleural Effusions
por: Nessim Kostandy, Erini, et al.
Publicado: (2023)

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study
por: Megdadi, Noor A., et al.
Publicado: (2021)

Hereditary Tyrosinemia Compounded With Hyperinsulinemic Hypoglycemia: Challenging Diagnosis of a Rare Case
por: Nasir, Sharmeen, et al.
Publicado: (2020)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
por: Gil-Martínez, Jon, et al.
Publicado: (2021)

Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy
por: Stinton, Chris, et al.
Publicado: (2017)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
por: Dweikat, Imad, et al.
Publicado: (2021)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver
por: Ren, Jilong, et al.
Publicado: (2022)

Heat Shock Response Associated with Hepatocarcinogenesis in a Murine Model of Hereditary Tyrosinemia Type I
por: Angileri, Francesca, et al.
Publicado: (2014)

Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya
por: Alobaidy, Hanna, et al.
Publicado: (2015)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
por: Najafi, Reza, et al.
Publicado: (2018)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
por: Barroso, Fábio, et al.
Publicado: (2020)

Novel Mutation of Tyrosinemia in a Child With Hypophosphatemic Rickets
por: Dogra, Surabhi, et al.
Publicado: (2022)

Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia
por: Hendrikse, Natalie M., et al.
Publicado: (2020)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
por: Daou, Karim N., et al.
Publicado: (2021)

Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma
por: Blackburn, Patrick R., et al.
Publicado: (2016)

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia
por: HONAR, Naser, et al.
Publicado: (2017)

Severe neurological crisis in adult patients with Tyrosinemia type 1
por: Dawson, Charlotte, et al.
Publicado: (2020)

Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I
por: Zhang, Ludi, et al.
Publicado: (2016)

Case report: ADHD and prognosis in tyrosinemia type 1
por: Barone, Helene, et al.
Publicado: (2023)

Diagnosis of metastatic fibrolamellar hepatocellular carcinoma by endoscopic ultrasound-guided fine needle aspiration
por: Crowe, Amanda, et al.
Publicado: (2011)

Hereditary orotic aciduria identified by newborn screening
por: Staretz-Chacham, Orna, et al.
Publicado: (2023)

Comment on Pancreatitis in Type 1 Tyrosinemia
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Newborn screening in the genomics era
por: Rego, Shannon
Publicado: (2014)

Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
por: Macias, Iratxe, et al.
Publicado: (2019)

Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1
por: Angileri, Francesca, et al.
Publicado: (2016)

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism
por: Thompson, Whitney S., et al.
Publicado: (2020)

In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions
por: Nicolas, Clara T., et al.
Publicado: (2022)

mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
por: Neuckermans, Jessie, et al.
Publicado: (2023)

Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
por: Sethuram, Swathi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbfuu78fvotpp594kle9us7eeu